Abstract: Provided are a system and method for displaying an item list, comprising: a list generator on a device that associates a list of items of interest at a retail establishment with feedback data according to locations of the items of interest relative to a location of the device; a location server that determines the locations of the items of interest relative to the location of the device; and an updater that reorders the list of items of interest and associates the feedback data with the reordered list of according to current locations of the items of interest relative to the location of the device. When the device is at a closest item of interest having a predetermined feedback data, the closest item of interest is swiped or removed from the list of items of interest displayed at the user interface, and the list of items of interest is reordered so that the next closest item of interest has the predetermined feedback data.

Abstract: Provided are a system and method for displaying an item list, comprising: a list generator on a device that associates a list of items of interest at a retail establishment with feedback data according to locations of the items of interest relative to a location of the device; a location server that determines the locations of the items of interest relative to the location of the device; and an updater that reorders the list of items of interest and associates the feedback data with the reordered list of according to current locations of the items of interest relative to the location of the device. When the device is at a closest item of interest having a predetermined feedback data, the closest item of interest is swiped or removed from the list of items of interest displayed at the user interface, and the list of items of interest is reordered so that the next closest item of interest has the predetermined feedback data.

Abstract: Disclosed in certain embodiments is a pharmaceutical composition comprising a sugar; a Krebs cycle intermediate, precursor of a Krebs cycle intermediate, salt thereof, or combination thereof; and a component selected from the group consisting of an unsaturated lipid, phenylethylamine, a soluble calcium compound, or a combination thereof.

Abstract: Disclosed in certain embodiments is a pharmaceutical composition comprising a sugar; a Krebs cycle intermediate, precursor of a Krebs cycle intermediate, salt thereof, or combination thereof; and a component selected from the group consisting of an unsaturated lipid, phenylethylamine, a soluble calcium compound, or a combination thereof.

Abstract: Disclosed in certain embodiments is a pharmaceutical composition comprising a sugar; a Krebs cycle intermediate, precursor of a Krebs cycle intermediate, salt thereof, or combination thereof; and a component selected from the group consisting of an unsaturated lipid, phenylethylamine, a soluble calcium compound, or a combination thereof.

Abstract: Disclosed in certain embodiments is a pharmaceutical composition comprising a sugar; a Krebs cycle intermediate, precursor of a Krebs cycle intermediate, salt thereof, or combination thereof; and a component selected from the group consisting of an unsaturated lipid, phenylethylamine, a soluble calcium compound, or a combination thereof.

Abstract: Disclosed in certain embodiments is a pharmaceutical composition comprising a sugar; a Krebs cycle intermediate, precursor of a Krebs cycle intermediate, salt thereof, or combination thereof; and a component selected from the group consisting of an unsaturated lipid, phenylethylamine, a soluble calcium compound, or a combination thereof.

Abstract: Administration of aminopyridine, preferably 3,4-diaminopyridine, increases motor strength and Functional Independence Measure in humans afflicted with diseases of the anterior horn cells, e.g., amyotrophic lateral sclerosis.